SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Clover Health Investments " 5 found 🔀 AI-powered Shuffle
Clover Health (CLOV) Stock Looks Reasonable Despite New 5 Star Ratings
Clover Health Investments has seen sharp swings in its share price in recent years, and the stock closed at US$4.79 most recently. With the business in the spotlight after new Medicare plan ratings, the question for investors is whether that price can be explained by its sales. The stock has delivered a very large 3 year return of about 365.0%, which puts a lot of weight on whether current revenue levels and future top line potential can support today’s valuation. Clover Health’s Medicare...
Clover Health Sees PPO Edge, Cohort Gains as Medicare Advantage Pricing Tightens
Clover Health Investments (NASDAQ:CLOV) is positioning its Medicare Advantage business to benefit from industry pricing discipline, member retention and the maturation of member cohorts, Interim Chief Financial Officer Clay Thornton said at Jefferies’ Healthcare Services and Technology Conference in
Clover Health (CLOV) Stock Looks Fairly Priced Despite Profit Turnaround
Clover Health Investments has staged a very strong three year run, yet the current checks still suggest the stock leans cheap rather than fully pricing in that shift in fortunes. The share price has returned about 3.3x over three years, which puts recent trading firmly in the high move bracket for this period. Profitability progress and Medicare Advantage membership growth can support the case for the current valuation, while higher medical costs and healthcare usage remain a clear risk to...
Jim Cramer Says Clover Health Was a Good Speculative Pick But Still Prefers UnitedHealth and CVS
Clover Health Investments, Corp. (NASDAQ:CLOV) was among the stocks on Jim Cramer’s radar on Mad Money, as he advised investors to care about where a stock is going, not where it has been. A caller referenced Cramer’s previous comment, calling it speculative, and noted that the company reported GAAP profitability in Q1 2026 and guided […]
Clover Health Investments Q4 Earnings Call Highlights
Clover Health Investments (NASDAQ:CLOV) executives used the company’s fourth-quarter 2025 earnings call to emphasize a combination of profitability and rapid Medicare Advantage membership growth during what they described as a period of elevated utilization across the industry. Chief Executive Offi